Olema Pharmaceuticals, Inc.
OLMA • NASDAQ
Olema Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean Bohen, with a market cap of $1.5B.
Market Cap$1.5B
Employees76.0
CEOSean Bohen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Olema Pharmaceuticals, Inc. FAQ
Common questions about Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.
Olema Pharmaceuticals, Inc. has approximately 76 employees.